养血安胎汤通过多靶点调控增殖性蜕膜基质细胞分化治疗不明原因复发性流产
本研究以Clark小鼠URSA模型和单细胞RNA测序探索养血安胎汤(YXAT)治疗不明原因复发性流产的机制。YXAT显著改善URSA小鼠蜕膜化与妊娠结局,恢复增殖性蜕膜基质细胞(proDSC)数量及Lgals1表达,并减弱NK细胞-proDSC异常通讯,效果优于地屈孕酮。人URSA样本验证了proDSC异常下调的临床相关性。
要点
- YXAT可恢复URSA小鼠proDSC数量并改善妊娠结局,效果优于地屈孕酮。
- Lgals1为YXAT调控proDSC分化的候选关键基因。
- YXAT减弱URSA中NK细胞-proDSC的异常炎症与免疫抑制信号。
核心结论
- proDSC分化紊乱与URSA小鼠蜕膜化缺陷及不良妊娠表型相关。
- YXAT干预伴随proDSC丰度恢复、Lgals1表达回升及NK细胞-proDSC信号正常化。
研究设计与样本
- 建立经典Clark小鼠URSA模型验证YXAT对流产的改善作用。
- 采用单细胞RNA测序构建妊娠第7.5天模型组与YXAT治疗组小鼠子宫单细胞图谱。
- 通过蜕膜化标志物检测、拟时序分析与细胞间通讯分析验证YXAT对DSC亚型分化的调控。
- 在动物与临床样本中验证YXAT对URSA异常DSC分化的调节作用。
主要发现
- YXAT显著改善URSA小鼠蜕膜化并改善妊娠结局。
- proDSC在URSA小鼠中异常下调,YXAT可恢复其数量且效果显著优于阳性药地屈孕酮。
- 整合分析鉴定Lgals1为YXAT调控且与proDSC分化相关的关键重叠基因。
- URSA小鼠NK细胞-proDSC通讯增强,涉及Spp1-Cd44、Gzma-Pard3等炎症激活及Spp1-(Itgav+Itgb5)、Lamb2-Dag1等免疫抑制配受体对,YXAT可减弱这些异常。
- 人URSA样本进一步验证proDSC异常下调。
关键数值与推荐
- URSA约占所有复发性自然流产的50%。
- YXAT作为院内中药制剂用于URSA治疗已逾30年,临床有效且安全。
临床怎么用
- YXAT可能通过恢复proDSC分化与Lgals1表达、调节NK细胞-proDSC通讯改善URSA妊娠结局。
- proDSC数量与Lgals1表达或可作为评估YXAT疗效的候选生物学指标。
局限性
- 研究以相关性观察为主,Lgals1作为候选调控因子仍需进一步因果验证。
- 机制结论主要基于小鼠模型与有限临床样本,尚需更大规模临床研究确认。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: Unexplained recurrent spontaneous abortion (URSA) accounts for approximately 50% of all recurrent spontaneous abortion cases, severely endangering the physical and mental health of women of childbearing age. Yang-Xue-An-Tai Decoction (YXAT), a traditional Chinese medicine (TCM) in-hospital preparation, has been clinically effective and safe for URSA treatment for over 30 years, but its underlying mechanism remains unclear. AIM OF THE STUDY: The purpose of this study was to explore the pharmacological mechanism of YXAT in the treatment of URSA, focusing on clarifying its multi-target mechanism in regulating the differentiation of decidual stromal cell (DSC) subtypes. MATERIALS AND METHODS: The classic Clark mouse model of URSA was established to verify YXAT's improvement effect on abortion. Single-cell RNA sequencing (scRNA-seq) was employed to construct the uterine single-cell atlas of model and YXAT-treated mice at gestational day 7.5 (GD7.5). YXAT's regulation on decidualization was verified by detecting decidualization markers; decidual stromal cell subtypes were analyzed, and its regulatory effect on subtype differentiation was confirmed via pseudotime analysis and intercellular communication. Moreover, YXAT's role in regulating abnormal decidual stromal cell differentiation in URSA was validated in animal and clinical samples. RESULTS: YXAT significantly improved decidualization and improved pregnancy outcomes in URSA mice. Subcluster analysis of DSCs revealed that proliferating DSCs (proDSCs)-a central hub for DSC differentiation-were abnormally downregulated in URSA mice, and this reduction was restored by YXAT, with a significantly better effect than that of the positive drug dydrogesterone. Integrated analysis identified Lgals1 as a key overlapping gene regulated by YXAT and linked to proDSC differentiation. We propose that Lgals1 acts as a candidate regulator, and the recovery of Lgals1 expression coincides with the restoration of proDSC differentiation following YXAT treatment. Additionally, URSA mice exhibited enhanced NK cell-proDSC communication with excessive inflammatory activation (e.g., Spp1-Cd44, Gzma-Pard3) and immune suppression-related ligand-receptor pairs (e.g., Spp1-(Itgav + Itgb5), Lamb2-Dag1), which were attenuated by YXAT. The abnormal downregulation of proDSCs was further verified in human URSA samples, highlighting its clinical relevance. CONCLUSIONS: Disordered proDSC differentiation correlates with defective decidualization and adverse pregnancy phenotypes in URSA mice. Multiple favorable cellular and molecular changes are observed alongside YXAT intervention, including recovered proDSC abundance, restored expression of the differentiation-associated gene Lgals1, and normalized abnormal NK cell-proDSC intercellular signaling. These correlative observations offer new insights into the clinical potential of YXAT and advance our understanding of TCM interventions against URSA.
引用
- Li G, Hu L, Tang J, et al. Yang-Xue-An-Tai Decoction Treats URSA by regulating the differentiation of proliferating decidual stromal cells through multiple targets. J Ethnopharmacol. 2026. PMID: 42364671. doi:10.1016/j.jep.2026.122133
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。